BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36972544)

  • 1. Effect of Medicare Advantage on Hospital Readmission and Mortality Rankings.
    Oseran AS; Wadhera RK; Orav EJ; Figueroa JF
    Ann Intern Med; 2023 Apr; 176(4):480-488. PubMed ID: 36972544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure.
    Kyanko K; Sahay KM; Wang Y; Li SX; Schreiber M; Hager M; Myers R; Johnson W; Zhang J; Krumholz H; Suter LG; Triche EW
    JAMA Netw Open; 2024 Jun; 7(6):e2414431. PubMed ID: 38829614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
    Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
    JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Inclusion of Medicare Advantage Patients in Hospitals' Risk-Standardized Readmission Rates, Performance, and Penalty Status.
    Panagiotou OA; Voorhies KR; Keohane LM; Kim D; Adhikari D; Kumar A; Rivera-Hernandez M; Rahman M; Gozalo P; Gutman R; Mor V; Trivedi AN
    JAMA Netw Open; 2021 Feb; 4(2):e2037320. PubMed ID: 33595661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data.
    Kumar A; Rahman M; Trivedi AN; Resnik L; Gozalo P; Mor V
    PLoS Med; 2018 Jun; 15(6):e1002592. PubMed ID: 29944655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure.
    Figueroa JF; Wadhera RK; Frakt AB; Fonarow GC; Heidenreich PA; Xu H; Lytle B; DeVore AD; Matsouaka R; Yancy CW; Bhatt DL; Joynt Maddox KE
    JAMA Cardiol; 2020 Dec; 5(12):1349-1357. PubMed ID: 32876650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional associations between Medicare Advantage penetration and administrative claims-based measures of hospital outcomes.
    Kulkarni VT; Shah SJ; Bernheim SM; Wang Y; Normand SL; Han LF; Rapp MT; Drye EE; Krumholz HM
    Med Care; 2012 May; 50(5):406-9. PubMed ID: 22456113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Do the Hospital Prices Paid by Medicare Advantage Plans and Commercial Plans Compare With Medicare Fee-for-Service Prices?
    Maeda JLK; Nelson L
    Inquiry; 2018; 55():46958018779654. PubMed ID: 29888626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Medicare Advantage Penetration With Per Capita Spending, Emergency Department Visits, and Readmission Rates Among Fee-for-Service Medicare Beneficiaries With High Comorbidity Burden.
    Park S; Langellier BA; Burke RE; Figueroa JF; Coe NB
    Med Care Res Rev; 2021 Dec; 78(6):703-712. PubMed ID: 32842874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of Publicly Reported Hospital Readmission Measures to Unreported Conditions and Other Patient Populations: A Cross-sectional All-Payer Study.
    Butala NM; Kramer DB; Shen C; Strom JB; Kennedy KF; Wang Y; Valsdottir LR; Wasfy JH; Yeh RW
    Ann Intern Med; 2018 May; 168(9):631-639. PubMed ID: 29582086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Hospitals' Engagement in Value-Based Reforms and Readmission Reduction in the Hospital Readmission Reduction Program.
    Ryan AM; Krinsky S; Adler-Milstein J; Damberg CL; Maurer KA; Hollingsworth JM
    JAMA Intern Med; 2017 Jun; 177(6):862-868. PubMed ID: 28395006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission.
    Horwitz LI; Partovian C; Lin Z; Grady JN; Herrin J; Conover M; Montague J; Dillaway C; Bartczak K; Suter LG; Ross JS; Bernheim SM; Krumholz HM; Drye EE
    Ann Intern Med; 2014 Nov; 161(10 Suppl):S66-75. PubMed ID: 25402406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misclassification of Hospital Performance Under the Hospital Readmissions Reduction Program: Implications for Value-Based Programs.
    Shen C; Wadhera RK; Yeh RW
    JAMA Cardiol; 2021 Mar; 6(3):332-335. PubMed ID: 33052371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Did the Hospital Readmissions Reduction Program Reduce Readmissions without Hurting Patient Outcomes at High Dual-Proportion Hospitals Prior to Stratification?
    Yang Z; Huckfeldt P; Escarce JJ; Sood N; Nuckols T; Popescu I
    Inquiry; 2022; 59():469580211064836. PubMed ID: 35317683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.
    Hoffman GJ; Yakusheva O
    JAMA Netw Open; 2020 Apr; 3(4):e202044. PubMed ID: 32242906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries.
    Matlock DD; Groeneveld PW; Sidney S; Shetterly S; Goodrich G; Glenn K; Xu S; Yang L; Farmer SA; Reynolds K; Cassidy-Bushrow AE; Lieu T; Boudreau DM; Greenlee RT; Tom J; Vupputuri S; Adams KF; Smith DH; Gunter MJ; Go AS; Magid DJ
    JAMA; 2013 Jul; 310(2):155-62. PubMed ID: 23839749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study of Administrative Data to Identify High-Need Medicare Beneficiaries at Risk of Dying and Being Hospitalized.
    Bélanger E; Silver B; Meyers DJ; Rahman M; Kumar A; Kosar C; Mor V
    J Gen Intern Med; 2019 Mar; 34(3):405-411. PubMed ID: 30604120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of hospital readmission in Medicare Advantage and Fee-For-Service within same hospital.
    Jung DH; DuGoff E; Smith M; Palta M; Gilmore-Bykovskyi A; Mullahy J
    Health Serv Res; 2020 Aug; 55(4):587-595. PubMed ID: 32608522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Medicare Advantage enrollment on mammographic screening.
    Hung A; Stuart B; Harris I
    Am J Manag Care; 2016 Feb; 22(2):e53-9. PubMed ID: 26881320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Quality of Hospitals That Admit Medicare Advantage Patients vs Traditional Medicare Patients.
    Meyers DJ; Trivedi AN; Mor V; Rahman M
    JAMA Netw Open; 2020 Jan; 3(1):e1919310. PubMed ID: 31940041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.